149 related articles for article (PubMed ID: 11055616)
1. Postexposure varicella vaccination in nine-month-old children.
Kanra G; Ceyhan M; Ozmert E
Pediatr Infect Dis J; 2000 Oct; 19(10):1029-30. PubMed ID: 11055616
[No Abstract] [Full Text] [Related]
2. The immunogenicity and safety of live attenuated varicella-zoster virus vaccine in human immunodeficiency virus-infected children.
Taweesith W; Puthanakit T; Kowitdamrong E; Bunupuradah T; Wongngam W; Phasomsap C; Apornpong T; Bouko C; Pancharoen C
Pediatr Infect Dis J; 2011 Apr; 30(4):320-4. PubMed ID: 20975615
[TBL] [Abstract][Full Text] [Related]
3. Varicella vaccine revisited.
Seward J; Jumaan A; Schmid S
Nat Med; 2000 Dec; 6(12):1298-300. PubMed ID: 11100088
[No Abstract] [Full Text] [Related]
4. A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella.
Gershon AA; Levin MJ; Weinberg A; Song LY; LaRussa PS; Steinberg SP; Bartlett P;
Pediatr Infect Dis J; 2009 Jul; 28(7):653-5. PubMed ID: 19561431
[TBL] [Abstract][Full Text] [Related]
5. Human immune responses to live attenuated varicella vaccine.
Gershon AA
Rev Infect Dis; 1991; 13 Suppl 11():S957-9. PubMed ID: 1664134
[TBL] [Abstract][Full Text] [Related]
6. Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child.
Kramer JM; LaRussa P; Tsai WC; Carney P; Leber SM; Gahagan S; Steinberg S; Blackwood RA
Pediatrics; 2001 Aug; 108(2):E39. PubMed ID: 11483849
[TBL] [Abstract][Full Text] [Related]
7. Live attenuated varicella vaccine in healthy 12- to 24-month-old children.
Johnson CE; Shurin PA; Fattlar D; Rome LP; Kumar ML
Pediatrics; 1988 Apr; 81(4):512-8. PubMed ID: 2832819
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting--a pilot study.
Mor M; Harel L; Kahan E; Amir J
Vaccine; 2004 Dec; 23(3):325-8. PubMed ID: 15530676
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical studies of varicella vaccine at a regional hospital in Japan and proposal for a varicella vaccination program.
Ozaki T
Vaccine; 2013 Dec; 31(51):6155-60. PubMed ID: 24183712
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of high-titer live attenuated varicella vaccine in healthy young children.
Varis T; Vesikari T
J Infect Dis; 1996 Nov; 174 Suppl 3():S330-4. PubMed ID: 8896541
[TBL] [Abstract][Full Text] [Related]
11. Safety and Immunogenicity of the Live Attenuated Varicella Vaccine in Vietnamese Children Aged 12 Months to 12 Years: An Open-Label, Single-Arm Bridging Study.
Hung PV; Giang LTH; Toi PL; Thuc VTM; Anh BDT; Pho DC; Hung PN
Viruses; 2024 May; 16(6):. PubMed ID: 38932134
[TBL] [Abstract][Full Text] [Related]
12. Varicella vaccine: the American experience.
Gershon AA; LaRussa P; Hardy I; Steinberg S; Silverstein S
J Infect Dis; 1992 Aug; 166 Suppl 1():S63-8. PubMed ID: 1320652
[TBL] [Abstract][Full Text] [Related]
13. COMMENTARY: Significantly less anti-gC antibody detectable in sera collected after varicella vaccination than after the disease varicella.
Grose C; Juhn Y
Pediatr Infect Dis J; 2012 Nov; 31(11):1153-4. PubMed ID: 23069796
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of live varicella virus vaccine in children with human immunodeficiency virus type 1.
Armenian SH; Han JY; Dunaway TM; Church JA
Pediatr Infect Dis J; 2006 Apr; 25(4):368-70. PubMed ID: 16567993
[TBL] [Abstract][Full Text] [Related]
15. Varicella zoster virus: vaccination and implications in children with renal failure.
Fadrowski JJ; Furth SL
Expert Rev Vaccines; 2004 Jun; 3(3):291-8. PubMed ID: 15176945
[TBL] [Abstract][Full Text] [Related]
16. Study of tolerance and effectiveness of a varicella vaccine in leukemic children.
Bancillon A; Leblanc T; Baruchel A; Schaison G; Leverger G; Mallarmey D; Teuliere L
Nouv Rev Fr Hematol (1978); 1991; 33(6):555-6. PubMed ID: 1667953
[TBL] [Abstract][Full Text] [Related]
17. A comparison of safety, tolerability and immunogenicity of Oka/Merck varicella vaccine and VARILRIX in healthy children.
Lau YL; Vessey SJ; Chan IS; Lee TL; Huang LM; Lee CY; Lin TY; Lee BW; Kwan K; Kasim SM; Chan CY; Kaplan KM; Distefano DJ; Harmon AL; Golie A; Hartzel J; Xu J; Li S; Matthews H; Sadoff JC; Shaw A
Vaccine; 2002 Jul; 20(23-24):2942-9. PubMed ID: 12126906
[TBL] [Abstract][Full Text] [Related]
18. Responses of varicella zoster virus (VZV)-specific immunity in seropositive adults after inhalation of inactivated or live attenuated varicella vaccine.
Terada K; Niizuma T; Ogita S; Kataoka N
Vaccine; 2002 Nov; 20(31-32):3638-43. PubMed ID: 12399190
[TBL] [Abstract][Full Text] [Related]
19. Live attenuated varicella vaccine.
Gershon AA
Annu Rev Med; 1987; 38():41-50. PubMed ID: 3034136
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
